Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VeltexVLXC +12.61% 3-Year EBITDA Growth Rate is 37.80% as of Dec. 2025, which is at its 10-year median of 37.80. The stock has 4 warning signs investors should review. Among 526 Healthcare Providers & Services companies, Veltex ranks better than 83.08% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 37.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Veltex was 37.80% per year. The lowest was 37.80% per year. And the median was 37.80% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Veltex 3-Year EBITDA Growth Rate Related Terms
VLXC vs NIVF, RHEP, XCRT: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Veltex's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veltex 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veltex's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Veltex's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 37.80% mean?
Veltex (VLXC) has a 3-Year EBITDA Growth Rate of 37.80% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Veltex and its competitors. This is near median its historical median of 37.80. Over the past decade, Veltex's 3-Year EBITDA Growth Rate has ranged from 37.80 to 37.80. According to the industry distribution chart, Veltex ranks #89 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 16.9%.
Is Veltex's 3-Year EBITDA Growth Rate too high?
Veltex's current 3-Year EBITDA Growth Rate of 37.80% is near median its 10-year median of 37.80. Over the past 10 years, this metric has ranged from a low of 37.80 to a high of 37.80. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. Veltex's value of 37.80% is 270.6% above this industry median. Based on the distribution chart, Veltex ranks #89 out of 526 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Veltex's 3-Year EBITDA Growth Rate compare to NIVF and RHEP?
According to the Healthcare Providers & Services industry distribution chart, Veltex ranks #89 out of 526 companies for 3-Year EBITDA Growth Rate. This places Veltex in the top 17% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 10.20. Veltex's value of 37.80% is 270.6% above this benchmark. Historically, Veltex's own 3-Year EBITDA Growth Rate has ranged from 37.80 to 37.80 over the past decade. While the company's 10-year median is 37.80 vs. the industry median of 10.20, Veltex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veltex's current 3-Year EBITDA Growth Rate of 37.80% is 270.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Veltex and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veltex's current 3-Year EBITDA Growth Rate is 37.80%, which is near median its own 10-year median of 37.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veltex stock overvalued right now?
Based on GuruFocus' analysis, Veltex (VLXC) is currently considered Possible Value Trap. The stock's GF Value™ is $0.13, compared to a current price of $0.04 — trading 69.7% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 37.80%, which is near median its 10-year median of 37.80 and 270.6% above the Healthcare Providers & Services industry median of 10.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Veltex (VLXC), the current 3-Year EBITDA Growth Rate is 37.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Veltex Corp is a United States-based holding company. The company is engaged in the development and acquisition of companies that have established the latest modalities in the areas of health, wellness, and addiction recovery. The company is engaged in revolutionalization of rehab centres and treatment centres.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VLXC has been successfully added to your 
